MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 1, 2007; DOI: 10.1124/mol.106.027599


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.106.027599v1
71/6/1494    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, K. Y.
Right arrow Articles by Walker, J. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, K. Y.
Right arrow Articles by Walker, J. W


Received for publication June 7, 2006.
Revised February 28, 2007.
Accepted for publication March 1, 2007.

Interaction and Inhibitory Cross-Talk between Endothelin and ErbB Receptors in the Adult Heart

Ka Young Chung 1 Jeffery W Walker 2*

1 Molecular and Cellular Pharmacology, University of Wisconsin-Madison 2 Department of Physiology, University of Wisconsin-Madison

* Address correspondence to: E-mail: jwalker{at}physiology.wisc.edu

Abstract

Endothelin-1 (ET-1) regulates contractility and growth of the mammalian heart by binding ETA and ETB G-protein coupled receptors (GPCRs). To identify growth signaling pathways associated with ET-1 receptors in adult myocardium, a combined immunoprecipitation/proteomic analysis was performed. Signaling proteins thought to function downstream of ETA such as G{alpha}q, PLC-{beta}1, PKC{epsilon} and PKC{delta} were identified in immunoprecipitates of ETA by MALDI-TOF mass spectrometry. Also prominent were the growth factor receptor tyrosine kinases erbB2 and erbB4, as well as their downstream growth signaling effectors PI3-kinase, Akt, Raf-1, MEK and Erk. Western blot analysis confirmed co-immunoprecipitation of erbB2/4, PI3-kinase, and Akt with ETA, and confocal microscopy revealed their co-localization in cardiac transverse tubules (T-tubules). The erbB4 receptor ligand neuregulin-1{beta} (NRG1{beta}) promoted erbB2/4 tryosine phosphorylation and Akt serine phosphorylation in ventricular myocytes, whereas treatment with ET-1 did not. This observation argues against ET-1 growth signaling occurring via erbB2/4 transactivation in adult myocardium. ET-1 did however stimulate Erk1/2 phosphorylation and substantially blunted several NRG1{beta} mediated actions including erbB2/4 phosphorylation, serine phosphorylation of Akt, and negative inotropy. This inhibitory cross-talk between ETA and erbB2/4-Akt pathways was mimicked by a phorbol ester and blocked by pharmacological inhibition of PKC or MEK/Erk. The proteomic analysis and subsequent investigation of receptor cross-talk indicate that growth signaling between ETA and erbB pathways is fundamentally different in adult versus neonatal cardiac myocytes. The results may be relevant to cardiomyopathies associated with i) prolonged exposure to ET-1, ii) degeneration of T-tubules, and iii) therapies targeted at erbB2 inhibition.


Key words: Endothelin, NGF/EGF, Gq/11 family, Phospholipase C's, Protein Kinase C, Fluorescence techniques, Mass Spectroscopy


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Y. Chung, M. Kang, and J. W. Walker
Contractile regulation by overexpressed ETA requires intact T tubules in adult rat ventricular myocytes
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2391 - H2399.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics